BIOMAT Database Logo BIOMAT Database Logo

Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections. 1990

A D Tice, and P K Marsh, and P C Craven
Infections Limited, P. S., Tacoma, Washington 98405.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

A D Tice, and P K Marsh, and P C Craven
Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Treatment of serious infections with intravenous ciprofloxacin.
April 1987, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Ciprofloxacin versus ceftazidime in serious infections.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
February 1989, Journal of chemotherapy (Florence, Italy),
A D Tice, and P K Marsh, and P C Craven
Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
November 1989, The American journal of medicine,
A D Tice, and P K Marsh, and P C Craven
Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
November 1989, The American journal of medicine,
Copied contents to your clipboard!